Nutrition and psoriasis

Clinics in Dermatology

Volumn 28, Issue 6, 2010, Pages 615-626

  Ricketts, Janelle R ^a   Rothe, Marti J ^a   Grant Kels, Jane M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; CALCITRIOL; COLESTYRAMINE; CYANOCOBALAMIN; CYCLOSPORIN A; DOCOSAHEXAENOIC ACID; ETRETIN; FISH OIL; GLITAZONE DERIVATIVE; ICOSAPENTAENOIC ACID; INOSITOL; LIAROZOLE; N [4 [2 ETHYL 1 (1H 1,2,4 TRIAZOL 1 YL)BUTYL]PHENYL] 2 BENZOTHIAZOLAMINE; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PIOGLITAZONE; PLACEBO; RETINOIC ACID; RETINOL; ROSIGLITAZONE; SELENIUM; TAURINE; UBIDECARENONE; UNINDEXED DRUG; VITAMIN D; ZINC;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BEDTIME DOSAGE; CALORIC RESTRICTION; CELIAC DISEASE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ERYTHRODERMA; GLUTEN FREE DIET; HUMAN; LOW CALORY DIET; LOW DRUG DOSE; METABOLIC SYNDROME X; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RISK FACTOR; SELENIUM DEFICIENCY; SINGLE DRUG DOSE; SKIN DEFECT; SYSTEMIC THERAPY; TH1 CELL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ALCOHOL DRINKING; COMBINED MODALITY THERAPY; DIET, GLUTEN-FREE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; PSORIASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELENIUM; TRETINOIN; VITAMIN B 12;

EID: 77958545984     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2010.03.027     Document Type: Article

References (98)

1. Mason A.R., Mason J., Cork M., Dooley G., Edwards G. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev 2009, CD005028.
2. Gupta A.K., Ellis C.N., Tellner D.C., Anderson T.F., Voorhees J.J. Double-blind, placebo-controlled study to evaluate the efficacy of fish oil and low-dose UVB in the treatment of psoriasis. Br J Dermatol 1989, 120:801-807.
3. Maurice P.D., Allen B.R., Barkley A.S., Cockbill S.R., Stammers J., Bather P.C. The effects of dietary supplementation with fish oil in patients with psoriasis. Br J Dermatol 1987, 117:599-606.
4. Ziboh V.A., Cohen K.A., Ellis C.N., et al. Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects. Arch Dermatol 1986, 122:1277-1282.
5. Kragballe K., Fogh K. Low-fat diet supplemented with dietary fish oil (MAX-EPA) and results in improvement of psoriasis and in formation of leukotriene B5. Acta Derm Venereol 1989, 69:23-28.
6. Kojima T., Terano T., Tanabe E., Okamoto S., Tamura Y., Yoshida S. Effect of highly purified eicosapentaenoic acid on psoriasis. J Am Acad Dermatol 1989, 21:150-151.
7. Schena D., Chieregato G.C., de Gironcoli M., et al. Increased erythrocyte membrane arachidonate and platelet malondialdehyde (MDA) production in psoriasis: normalization after fish oil. Acta Derm Venereol (Stockh) 1989, 146(suppl):42-44.
8. Kettler A.H., Baughn R.E., Orengo I.F., Black H., Wolf J.E. Effect of dietary fish oil supplementation on psoriasis. J Am Acad Dermatol 1988, 18:1267-1273.
9. Bjørneboe A., Smith A.K., Bjørneboe G.E., Thune P.O., Drevon C.A. Effect of dietary supplementation with n-3 Fatty Acids. Br J Dermatol 1988, 118:77-83.
10. Bittiner S.B., Cartwright I., Tucker W.F.G., Bleehen S.S. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet 1988, 331:378-380.
11. Soyland E., Funk J., Rajka G., et al. Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis. N Engl J Med 1993, 328:1812-1816.
12. Danno K., Sugie N. Combination therapy with low-dose etretinate and eicosapentaenoic acid for psoriasis vulgaris. J Dermatol 1998, 25:703-705.
13. Gupta A.K., Ellis C.N., Goldfarb M.T., Hamilton T.A., Voorhees J.J. The role of fish oil in psoriasis. A randomized, double-blind, placebo-controlled study to evaluate the effects of fish oil and topical corticosteroid therapy in psoriasis. Int J Dermatol 1990, 29:591-595.
14. Escobar S.O., Achenbach R., Iannantuono R., Torem V. Topical fish oil in psoriasis-a controlled and blind study. Clin Exp Dermatol 1992, 17:159-162.
15. Henneicke-von Zepelin H.H., Mrowietz U., Färber L., et al. Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study. Br J Dermatol 1993, 129:713-717.
16. Grimminger F., Mayser P., Papavassilis C., et al. A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile. Clin Investig 1993, 71:634-643.
17. Mayser P., Mrowietz U., Arenberger P., et al ω-3 Fatty acid-based lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998, 38:539-547.
18. Marsden J.R. Effect of dietary fish oil on hyperlipidaemia due to isotretinoin and etretinate. Hum Toxicol 1987, 6:219-222.
19. Ashley J.M., Lowe N.J., Borok M.E., Alfin-Slater R.B. Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy. J Am Acad Dermatol 1988, 19:76-82.
20. Elzinga L., Kelley V.E., Houghton D.C., et al. Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporin. Transplantation 1987, 43:271-274.
21. Stoof T.J., Korstanje H.J., Bilo H.J.G., et al. Does fish oil protect renal function in cyclosporin-treated psoriasis patients?. J Intern Med 1989, 226:437-441.
22. Santos J., Queirós J., Silva F., et al. Effects of fish oil in cyclosporine-treated renal transplant recipients. Transplant Proc 2000, 32:2605-2608.
23. Jankovic S., Raznatovic M., Marinkovic J., Jankovic J., Maksimovic N. Risk factors for psoriasis: a case-control study. J Dermatol 2009, 36:328-334.
24. Behnam S.M., Behnam S.E., Koo J.Y. Alcohol as a risk factor for plaque-type psoriasis. Cutis 2005, 76:181-185.
25. Zamboni A. Dietary behavior in psoriatic patients. Acta Derm Venereol (Stockh) 1989, 146(suppl):182-183.
26. Poikolainen K., Reunala T., Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994, 130:473-477.
27. Gupta M.A., Schork N.J., Gupta A.K., Ellis C.N. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993, 28:730-732.
28. Poikolainen K., Karvonen J., Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 1999, 135:1490-1493.
29. Lithell H., Bruce A., Gustafsson I.B., et al. A fasting and vegetarian diet treatment trial on chronic inflammatory disorders. Acta Derm Venereol (Stockh) 1983, 63:397-403.
30. Rucevic I., Perl A., Barisic-Drusko V., Adam-Perl M. The role of the low energy diet in psoriasis vulgaris treatment. Coll Antropol 2003, 27(suppl 1):41-48.
31. Gisondi P., Del Giglio M., Di Francesco V., Zamboni M., Girolomoni G. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 2008, 88:1242-1247.
32. Saraceno R., Ruzzetti M., De Martino M.U., et al. Does metabolic syndrome influence psoriasis?. Eur Rev Med Pharmacol Sci 2008, 12:339-341.
33. Cohen A.D., Sherf M., Vidavsky L., Vardy D.A., Shapiro J. Meyerovitch. Association between psoriasis and the metabolic syndrome. Dermatol 2008, 216:152-155.
34. Neimann A.L., Shin D.B., Wang X., Margolis D., Troxel A.B., Gelfand J.M. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006, 55:829-835.
35. Sommer D.M., Jenisch S., Suchan M., Christophers E., Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006, 298:321-328.
36. Cohen A.D., Dreiher J., Shapiro Y., et al. Psoriasis and diabetes: a population-based cross sectional study. J Eur Acad Dermatol Venereol 2008, 22:585-589.
37. Shapiro J., Cohen A.D., David M., et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007, 56:629-634.
38. Rocha-Pereira P., Santos-Silva A., Rebelo I., Figueiredo A., Quintanilha A., Teixeira F. Dislipidemia and oxidative stress in mild and severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001, 303:33-39.
39. Qureshi A.A., Choi H.K., Setty A.R., Curhan G.C. Psoriasis and the risk of diabetes and hypertenision. A prospective study of US female nurses. Arch Dermatol 2009, 145:379-382.
40. Robertshaw H., Friedmann P.S. Pioglitazone: a promising new therapy for psoriasis. Br J Dermatol 2005, 152:189-191.
41. Shafiq N., Malhotra S., Pandhi P., Gupta M., Kumar B., Sandhu K. Pilot trial: pioglitazone versus placebo in patients with plaque psoriasis (the P6). Int J Dermatol 2005, 44:328-333.
42. Krentz A.J., Friedmann P.S. Type 2 diabetes, psoriasis and thiazolidinediones. Int J Clin Pract 2006, 60:362-363.
43. Ellis C.N., Barker J.N., Haig A.E., Parker C.A., Daly S., Jayawardene D.A. Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone. Am J Clin Dermatol 2007, 8:93-102. Avandia Psoriasis Study Group.
44. Ojetti V., Aguilar Sanchez J., et al. High prevalence of celiac disease in psoriasis. Am J Gastroenterol 2003, 98:2574-2575.
45. Birkenfeld S., Dreiher J., Weitzman D., Cohen A.D. Coeliac disease associated with psoriasis. Br J Dermatol 2009, 1-4.
46. Ojetti V., De Simone C., Aguilar Sanchez J., et al. Malabsorption in psoriatic patients: cause or consequence?. Scand J Gastroenterol 2006, 41:1267-1271.
47. Collin P., Pukkala E., Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996, 38:528-530.
48. Reunala T., Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997, 136:315-318.
49. Kia K., Nair R.P., Ike R.W., Hiremagalore R., Elder J.T., Ellis C.N. Prevalence of antigliadin antibodies in patients with psoriasis is not elevated compared with controls. Am J Clin Dermatol 2007, 8:301-305.
50. Michaelsson G., Gerden B., Ottosson M., et al. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin. Br J Dermatol 1993, 129:667-673.
51. Lindqvist U., Rudsander A., Bostrom A., Nilsson B., Michaelsson G. IgA antibodies to gliadin and celiac disease in psoriatic arthritis. Rheumatology 2002, 41:31-37.
52. Woo W.K., McMillan S.A., Watson R.G., McCluggage W.G., Sloan J.M., McMillan J.C. Coeliac disease-associated antibodies correlate with psoriasis activity. Br J Dermatol 2004, 151:891-894.
53. Damasiewicz-Bodzek A., Wielkoszynski T. Serologic markers of celiac disease in psoriatic patients. J Eur Acad Dermatol Venereol 2008, 22:1055-1061.
54. Michaelsson G., Kraaz W., Gerden B., et al. Increased lymphocytes infiltration in duodenal mucosa from patients with psoriasis and serum IgA antibodies to gliadin. Br J Dermatol 1995, 133:896-904.
55. Michaelsson G., Gerden B., Hagforsen E., et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol 2000, 142:44-51.
56. Addolorato G., Parente A., de Lorenzi G., et al. Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature. Digestion 2003, 68:9-12.
57. Ruedemann R. Treatment of psoriasis with large doses of vitamin B12, 1,110 micrograms per cubic centimeter, preliminary clinical report. AMA Arch Dermatol Syphilol 1954, 69:738-739.
58. 12 of value in psoriasis?. Br J Med 1962, 29:1729-1730.
59. 12 cream containing avocado oil in the therapy of plaque psoriasis. Dermatol 2001, 203:141-147.
60. Bos J.D., Spuls P.I. Topical treatments in psoriasis: today and tomorrow. Clin Dermatol 2008, 26:432-437.
61. Reichrath J., Lehmann B., Carlberg C., Varani J., Zouboulis C.C. Vitamins as hormones. Horm Metab Res 2007, 39:71-84.
62. Holick M.F. 1,25-Dihydroxyvitamin D3 and the skin: a unique application for the treatment of psoriasis. Proc Soc Exp Biol Med 1989, 191:246-257.
63. Morimoto S., Kumahara Y. A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3. Med J Osaka Univ 1985, 35:51-54.
64. Morimoto S., Yoshikawa K., Kozuka T., et al. Treatment of psoriasis vulgaris with oral 1 alpha,25-dihydroxyvitamin D3-report of two cases. J Dermatol 1987, 14:59-62.
65. Smith E.L., Pincus S.H., Donovan L., Holick M.F. A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol 1988, 19:516-528.
66. Huckins D., Felson D.T., Holick M. Treatment of psoriatic arthritis with oral 1-25 dihydroxyvitamin D3: a pilot study. Arthritis Rheum 1990, 1723-1727.
67. el-Azhary R.A., Peters M.S., Pittelkow M.R., Kao P.C., Muller S.A. Efficacy of vitamin D3 derivatives in the treatment of psoriasis vulgaris: a preliminary report. Mayo Clin Proc 1993, 68:835-841.
68. Siddiqui M.A., Al-Kwawajah M.M. Vitamin D3 and psoriasis: a randomized double-blind placebo-controlled study. J Dermatolog Treat 1990, 1:243-245.
69. Holick M.F., Chen M.L., Kong X.F., Sanan D.K. Clinical uses for calciotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective. J Investig Dermatol Symp Proc 1996, 1:1-9.
70. Park B., Park J., Lee D., Youn J., Kim I. Vitamin D receptor polymorphism is associated with psoriasis. J Invest Dermatol 1999, 112:113-116.
71. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353-373.
72. Matz H., Orion E., Wolf R. Balneotherapy in dermatology. Dermatol Ther 2003, 16:132-140.
73. Juhlin L., Edqvist L.E., Ekman L.G., Ljunghall K., Olsson M. Blood glutathione peroxidase levels in skin diseases: Effect of selenium and vitamin E treatment. Acta Derm Venereol (Stockh) 1982, 62:211-214.
74. Fairris G.M., Lloyd B., Hinks L., Perkins P.J., Clayton B.E. The effect of supplementation with selenium and vitamin E in psoriasis. Ann Clin Biochem 1989, 26:83-88.
75. Fairris G.M., Lloyd B., Hinks L., White J.E. Selenium concentrations in psoriasis and eczema. Br J Dermatol 1987, 116:436.
76. Michaelsson G., Berne B., Carlmark B., Strand A. Selenium in whole blood and plasma is decreased in patients with moderate and severe psoriasis. Acta Derm Venereol (Stockh) 1989, 69:29-34.
77. Serwin A.B., Waşowicz W., Gromadzińska J., Chodynicka B. Selenium status in psoriasis and its relationship with alcohol consumption. Biol Trace Elem Res 2002, 89:127-140.
78. Serwin A.B., Waşowicz W., Gromadzińska J., Chodynicka B. Selenium status in psoriasis and its relations to duration and severity of the disease. Nutrition 2003, 19:301-304.
79. Harvima R.J., Jagerroos H., Kajander E.O., et al. Screening effects of selenomethionine-enriched yeast supplementation on various immunological and chemical parameters of skin and blood in psoriatic patients. Acta Derm Venereol (Stockh) 1993, 73:88-89.
80. Kharaeva Z., Gostova E., De Luca C., Raskovic D., Korkina L. Clinical and biochemical effects of coenzyme Q10, Vitamin E, and Selenium supplementation to psoriasis patients. Nutrition 2009, 25:295-302.
81. Serwin A.B., Wasowicz W., Chodynicka B. Selenium supplementation, soluble tumor necrosis factor-alpha receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B. Nutrition 2006, 22:860-864.
82. Serwin A.B., Mysliwiec H., Hukalowicz K., Porebski P., Borawska M., Chodynicka B. Soluble tumor necrosis factor-alpha receptor type 1 during selenium supplementation in psoriasis patients. Nutrition 2003, 19:847-850.
83. Pinton J., Friden H., Kettaneh-Wold N., et al. Clinical and biological effects of balneotherapy with selenium-rich spa water in patients with psoriasis vulgaris. Br J Dermatol 1995, 133:344-347.
84. Majewski S., Janik P., Langner A., Glinska-Ferenz M., Swietochowska B., Sawicki I. Decreased levels of vitamin A in serum of patients with psoriasis. Arch Dermatol Res 1989, 280:499-501.
85. Marrakchi S., Kim I., Delaporte E., et al. Vitamin A and E blood levels in erythrodermic and pustular psoriasis associated with chronic alcoholism. Acta Derm Venereol 1994, 74:298-301.
86. Rollman O., Vahlquist A. Psoriasis and vitamin A. Plasma transport and skin content of retinol, dehydroretinol and carotenoids in adult patients versus healthy controls. Arch Dermatol Res 1985, 278:17-24.
87. Safavi K. Serum Vitamin A levels in psoriasis: results from the first National Health and Nutrition Examination Survey. Arch Dermatol 1992, 128:1130-1131.
88. Saurat J.-H. Retinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatment. J Am Acad Dermatol 1999, 41:S2-6.
89. Dockx P., Decree J., Degreef H. Inhibition of metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liazorole. Br J Dermatol 1995, 133:426-432.
90. Bovenschen H.J., Otero M.E., Langewouters A.M.G., et al. Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study. Br J Dermatol 2007, 156:263-270.
91. Allan S.J.R., Kavanagh G.M., Herd R.M., Savin J.A. The effect of inositol supplementation on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial. Br J Dermatol 2004, 150:966-969.
92. Burrows N.P., Turnbull A.J., Punchard N.A., Thompson R.P.H., Jones R.R. A trial of oral zinc supplementation in psoriasis. Cutis 1994, 54:117-118.
93. Roe D.A. The clinical and biochemical significance of taurine excretion in psoriasis. J Invest Dermatol 1962, 39:537-542.
94. Roe D.A., Weston M.O. Potential significance of free taurine in the diet. Nature 1965, 205:287-288.
95. Roe D.A. Nutrient requirements in psoriasis. N Y State J Med 1965, 65:1319-1326.
96. Zackheim H.S., Farber E.M. Taurine and psoriasis. J Invest Dermatol 1968, 50:227-230.
97. Zackheim H.S., Farber E.M. Low-protein diet and psoriasis. A hospital study. Arch Dermatol 1969, 99:580-586.
98. Zackheim H.S., Farber E.M. Rapid weight reduction and psoriasis. Arch Dermatol 1971, 103:136-140.